-
Mashup Score: 1Dr. Awsare: Biosimilars in an integrated model help lower drug costs - 2 month(s) ago
Sameer Awsare, MD, tells Pink Sheet that Kaiser Permanente’s unique integrated structure helps it succeed in adopting biosimilars, resulting in lower drug costs for patients without sacrificing safety and efficacy.
Source: permanente.orgCategories: General Medicine News, General HCPsTweet
Sameer Awsare, MD, FACP, assoc. exec. dir. of @TPMGDocCareers, shares how Kaiser Permanente’s integrated care model enables its successful adoption of biosimilar drugs, which help lower costs without losing safety and efficacy. Link: https://t.co/LqC3Z6mSfR #biosimilardrugs